Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
31 March 2020 | Story Leonie Bolleurs | Photo Gerhard de Jager
Prof Linda Basson recently returned from a three-month research expedition in Antarctica. Here she is, relaxing on the ice with the ever-inquisitive Adelie penguins having a gander at these strangers in their snowy world.
Prof Linda Basson recently returned from a three-month research expedition in Antarctica. Here she is, relaxing on the ice with the ever-inquisitive Adelie penguins having a gander at these strangers in their snowy world.

Very little is known about the parasites of Antarctica, which is a highly productive part of the oceans. These small organisms can be used very successfully to determine the health of this fragile ecosystem.

“Our research data can make significant contributions to the biodiversity of parasites, for a start. The data can also be very valuable to indicate the overall health of this large ecosystem – an ecosystem that drives many of the life-giving processes on our planet.” This is the belief of Prof Linda Basson from the Department of Zoology and Entomology at the University of the Free State (UFS). 

She is an aquatic parasitologist who concentrates on various parasites from a wide range of hosts, including vertebrates (fish and amphibians) and invertebrates (plankton, urchins, starfish, sea cucumbers and red-bait).

Prof Basson, together with PhD student Gerhard de Jager, was invited by Prof Isabelle Ansorge, Head of the School of Oceanography, University of Cape Town, to join her research team on the South African National Antarctic Programme (SANAE) Voyage 59 to Antarctica. 

Widen the scope of research 
“Our aim on this trip was to determine how we can collaborate with the various oceanographers to widen the scope of research normally performed on these voyages, in order to also include parasitological aspects. Once we arrived on the continent of Antarctica, we worked to collect a range of hosts from the Southern Ocean to screen these for the whole array of parasites,” she explains. 

No research of any kind on aquatic parasites has ever been done in Penguin Bukta and Akta Bukta, the specific areas where Prof Basson was based with other scientists and the rest of the Agulhas crew.

She adds: “Our research will contribute to the wider knowledge of parasites in marine environments, but specifically in this area where little to nothing is known.”

A chance of a lifetime 
“Antarctica was literally one of the top research destinations on my bucket list. Travelling to and working in Antarctica is a lifelong dream of mine. It was a chance of a lifetime that I could not miss out on,” says Prof Basson. 

Sharing her experience, she says a typical day on board the SA Agulhas II in Antarctica will start with a cup of good, quality coffee and a look at the prevailing weather on the stern of the ship. 

“One would always be amazed by the beautiful, ceaselessly changing water, the restless sea ice and the impressive ancient ice shelf in very invigorating temperatures, while an ethereal Snow Petrel swirls past and the occasional Adelie penguin comes to gaze and contemplate the presence of this large red structure floating in their habitat and obscuring their view. After tearing yourself away from this, the rest of the day would be spent either in the well-equipped laboratory working through collected samples, or else planning the next exciting collection in the intensely cold water.”

Remarkable journey 
To eternalise memories of this unique experience of almost three months, Prof Basson says that, “One cannot go without a fully charged camera with a large SD card, ready to capture the many facets of this exceedingly fragile but enchanting world of ice and sky, ever changing and all in innumerable shades of white”.

“This truly remarkable journey will forever be associated with a myriad of brilliant highlights.”

Finding it extremely difficult to single out a specific highlight, she listed a long list of memorable events, but as a scientist she will always remember “realising the wealth and cornucopia of microscopic life present in the southernmost of our oceans and seeing this first-hand under the microscope”.

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept